Picard Medical, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Picard Medical, Inc. (PMI) on March 17, 2026. The filing serves as a Regulation FD disclosure regarding a significant clinical milestone achieved by the Company's SynCardia Total Artificial Heart.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a clinical event and does not contain financial statement data.
Material Changes and Clinical Milestone
The primary material event reported is the successful long-term support of a patient using the SynCardia Total Artificial Heart:
- Patient Outcome: A 29-year-old patient was sustained entirely by the device for over four years while awaiting a donor transplant.
- Duration: The patient received continuous artificial heart support for over 1,600 days.
- Timeline: Implantation occurred on September 2, 2021, and a successful heart transplant was performed on February 24, 2026.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future financial performance, or specific risk factors beyond the standard disclaimer that the information is not deemed "filed" under the Exchange Act. The report highlights the clinical viability of the device as a bridge to transplant.
Key Facts for Investor Verification
- Verify the details of the press release furnished as Exhibit 99.1 regarding the 1,600-day survival record.
- Confirm the impact of this clinical milestone on the Company's regulatory strategy and market perception.
- Note that no financial data is included in this specific filing; refer to the most recent 10-K or 10-Q for financial status.